Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study

por Aviram, Joshua, Vysotski, Yelena, Berman, Paula, Lewitus, Gil M., Eisenberg, Elon, Meiri, David
Publicado 2020

A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis

por Berman, Paula, Futoran, Kate, Lewitus, Gil M., Mukha, Dzmitry, Benami, Maya, Shlomi, Tomer, Meiri, David
Publicado 2018

Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients

por Hergenrather, Jeffrey Y., Aviram, Joshua, Vysotski, Yelena, Campisi-Pinto, Salvatore, Lewitus, Gil M., Meiri, David
Publicado 2020

Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients

por Aviram, Joshua, Lewitus, Gil M., Vysotski, Yelena, Yellin, Ben, Berman, Paula, Shapira, Anna, Meiri, David
Publicado 2021

Sex differences in medical cannabis-related adverse effects

por Aviram, Joshua, Lewitus, Gil M., Vysotski, Yelena, Berman, Paula, Shapira, Anna, Procaccia, Shiri, Meiri, David
Publicado 2022

Full-Spectrum Cannabis Extract Microdepots Support Controlled Release of Multiple Phytocannabinoids for Extended Therapeutic Effect

por Uziel, Almog, Gelfand, Anat, Amsalem, Keren, Berman, Paula, Lewitus, Gil M., Meiri, David, Lewitus, Dan Y.
Publicado 2020

The heterogeneity and complexity of Cannabis extracts as antitumor agents

por Baram, Liran, Peled, Ella, Berman, Paula, Yellin, Ben, Besser, Elazar, Benami, Maya, Louria-Hayon, Igal, Lewitus, Gil M., Meiri, David
Publicado 2019

Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome

por Bar-Sela, Gil, Cohen, Idan, Campisi-Pinto, Salvatore, Lewitus, Gil M., Oz-Ari, Lanuel, Jehassi, Ayellet, Peer, Avivit, Turgeman, Ilit, Vernicova, Olga, Berman, Paula, Wollner, Mira, Moskovitz, Mor, Meiri, David
Publicado 2020

Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447

por Bar-Sela, Gil, Cohen, Idan, Campisi-Pinto, Salvatore, Lewitus, Gil M., Oz-Ari, Lanuel, Jehassi, Ayellet, Peer, Avivit, Turgeman, Ilit, Vernicova, Olga, Berman, Paula, Wollner, Mira, Moskovitz, Mor, Meiri, David
Publicado 2022

The association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injury

por Vered, Shiraz, Beiser, Alexa S., Sulimani, Liron, Sznitman, Sharon, Gonzales, Mitzi M., Aparicio, Hugo J., DeCarli, Charles, Scott, Matthew R., Ghosh, Saptaparni, Lewitus, Gil M., Meiri, David, Seshadri, Sudha, Weinstein, Galit
Publicado 2023

The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients

por Aviram, Joshua, Lewitus, Gil M., Vysotski, Yelena, Amna, Mahmoud Abu, Ouryvaev, Anton, Procaccia, Shiri, Cohen, Idan, Leibovici, Anca, Akria, Luiza, Goncharov, Dimitry, Mativ, Neomi, Kauffman, Avia, Shai, Ayelet, Bar-Sela, Gil, Meiri, David
Publicado 2022

Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients

por Aviram, Joshua, Lewitus, Gil M., Vysotski, Yelena, Uribayev, Anton, Procaccia, Shiri, Cohen, Idan, Leibovici, Anca, Abo-Amna, Mahmud, Akria, Luiza, Goncharov, Dmitry, Mativ, Neomi, Kauffman, Avia, Shai, Ayelet, Hazan, Or, Bar-Sela, Gil, Meiri, David
Publicado 2020